У нас вы можете посмотреть бесплатно How to Fix Drug Discovery & Manufacturing in the US или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Excelsior Sciences has developed a groundbreaking modular chemistry platform designed to support automation from the ground up. In the video with Cure, Excelsior Sciences's Co-Founder & CEO Mike Foley explains why traditional small-molecule chemistry has become a bottleneck—and how Excelsior is rebuilding it for automation, AI, and scalable manufacturing. Foley describes how chemistry designed for machines enables a more modular, repeatable approach to discovery, reducing the friction and delays between early research and manufacturing. With 85% of generic drugs in the US currently manufactured overseas, Excelsior’s automated approach makes it possible to reshore small-molecule discovery and manufacturing, creating a more resilient and strategically independent drug supply. Read more in an exclusive Q&A with Mike Foley here: https://wewillcure.com/insights/found... Cure is an affiliate of Deerfield Management. Excelsior is a portfolio company of Deerfield Management.